中国麻风皮肤病杂志 ›› 2023, Vol. 39 ›› Issue (1): 56-60.doi: 10.12144/zgmfskin202301056

• 综述 • 上一篇    下一篇

生物制剂治疗甲银屑病研究进展

谢晗1,曾同祥2   

  1. 1长江大学第二临床医学院，湖北荆州，434000；
    2荆州市中心医院皮肤科，荆州，434000
  • 出版日期:2023-01-15 发布日期:2022-11-28

Update of biological agents in the treatment of nail psoriasis

XIE Han1, ZENG Tongxiang2   

  1. 1 The Second Clinical Medical College of Yangtze University, Jingzhou 434000, China;
    2 Department of Dermatology, Jingzhou Central Hospital, Jingzhou 434000, China
  • Online:2023-01-15 Published:2022-11-28

PDF (PC)

262

摘要： 银屑病是一种慢性复发性炎症性皮肤病，约一半以上的患者出现指（趾）甲受累。甲银屑病使患者的生活质量受到严重影响。近年来，随着生物制剂在银屑病治疗中的广泛应用，患者的指（趾）甲症状也得到了显著缓解。本文总结了生物制剂在甲银屑病治疗中的研究进展，以期为研发针对性更强、疗效及安全性更高的生物制剂提供参考。

关键词: 甲银屑病, 生物制剂, 研究进展

Abstract: Psoriasis is a chronic recurrent inflammatory skin disease, about half of the patients with finger (toe) nail involvement. The life quality of patients with nail psoriasis is seriously affected. In recent years, with the widespread use of biological agents in the treatment of psoriasis, it has been found that patients with finger (toe) nail symptoms have been significantly relieved. This paper reviews the update of biological agents in the treatment of psoriasis, to provide reference for the development of more targeted, effective and safe biological agents.

Key words: nail psoriasis, biological agents, research progress